B7-H1, which represses EBV-Immortalized B cell killing by autologous T and NK Cells, is oppositely Regulated by c-Myc and EBV latency III program at both mRNA and secretory lysosome levels

Journal of Immunology

Volumn 189, Issue 1, 2012, Pages 181-190

  Durand Panteix, Stéphanie ^a   Farhat, Mona ^a   Youlyouz Marfak, Ibtissam ^a   Rouaud, Pauline ^a   Ouk Martin, Catherine ^a   David, Amandine ^a   Faumont, Nathalie ^a   Feuillard, Jean ^a,b   Jayat Vignoles, Chantal ^a  

^a CNRS   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MYC PROTEIN; PROGRAMMED DEATH 1 LIGAND 1; STAT1 PROTEIN;

ACTIN POLYMERIZATION; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CELL IMMORTALIZATION; CELL KILLING; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOLOGICAL SYNAPSE; INTERNALIZATION; LATENT PERIOD; LYMPHOBLASTOID CELL LINE; LYMPHOMA CELL LINE; LYSOSOME; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA ISOLATION; T LYMPHOCYTE; WESTERN BLOTTING;

ANTIGENS, CD274; B-LYMPHOCYTE SUBSETS; BIOLOGICAL TRANSPORT, ACTIVE; CELL DEATH; CELL LINE; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL SURVIVAL; DOWN-REGULATION; HERPESVIRUS 4, HUMAN; HUMANS; KILLER CELLS, NATURAL; LYSOSOMES; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; RNA, VIRAL; T-LYMPHOCYTE SUBSETS; VIRUS LATENCY;

EID: 84862868501     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102277     Document Type: Article

References (60)

1. Young, L. S., C. W. Dawson, and A. G. Eliopoulos. 2000. The expression and function of Epstein-Barr virus encoded latent genes. MP, Mol. Pathol. 53: 238-247.
2. Thorley-Lawson, D. A. 2001. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 1: 75-82. (Pubitemid 33741978)
3. Khanna, R., R. W. Slade, L. Poulsen, D. J. Moss, S. R. Burrows, J. Nicholls, and J. M. Burrows. 1997. Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift. J. Virol. 71: 8340-8346. (Pubitemid 27446411)
4. Middeldorp, J. M., and D. M. Pegtel. 2008. Multiple roles of LMP1 in Epstein-Barr virus induced immune escape. Semin. Cancer Biol. 18: 388-396.
5. Le Clorennec, C., T. S. Ouk, I. Youlyouz-Marfak, S. Panteix, C. C. Martin, J. Rastelli, E. Adriaenssens, U. Zimber-Strobl, J. Coll, J. Feuillard, and C. Jayat-Vignoles. 2008. Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis. J. Virol. 82: 6721-6733. (Pubitemid 351875147)
6. Le Clorennec, C., I. Youlyouz-Marfak, E. Adriaenssens, J. Coll, G. W. Bornkamm, and J. Feuillard. 2006. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53. Blood 107: 2070-2078. (Pubitemid 43289391)
7. Decker, L. L., L. D. Klaman, and D. A. Thorley-Lawson. 1996. Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J. Virol. 70: 3286-3289. (Pubitemid 26121950)
8. Erickson, K. D., and J. M. Martin. 1997. Early detection of the lytic LMP-1 protein in EBV-infected B-cells suggests its presence in the virion. Virology 234: 1-13. (Pubitemid 27316602)
9. Vazirabadi, G., T. R. Geiger, W. F. Coffin, III, and J. M. Martin. 2003. Epstein-Barr virus latent membrane protein-1 (LMP-1) and lytic LMP-1 localization in plasma membrane-derived extracellular vesicles and intracellular virions. J. Gen. Virol. 84: 1997-2008. (Pubitemid 36927228)
10. Ahsan, N., T. Kanda, K. Nagashima, and K. Takada. 2005. Epstein-Barr virus transforming protein LMP1 plays a critical role in virus production. J. Virol. 79: 4415-4424. (Pubitemid 40388378)
11. Najjar, I., F. Baran-Marszak, C. Le Clorennec, C. Laguillier, O. Schischmanoff, I. Youlyouz-Marfak, M. Schlee, G. W. Bornkamm, M. Raphaél, J. Feuillard, and R. Fagard. 2005. Latent membrane protein 1 regulates STAT1 through NF-kappaB-dependent interferon secretion in Epstein-Barr virus-immortalized B cells. J. Virol. 79: 4936-4943. (Pubitemid 40464244)
12. Faumont, N., S. Durand-Panteix, M. Schlee, S. Grömminger, M. Schuhmacher, M. Hölzel, G. Laux, R. Mailhammer, A. Rosenwald, L. M. Staudt, et al. 2009. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells. J. Virol. 83: 5014-5027.
13. Schlee, M., M. Hölzel, S. Bernard, R. Mailhammer, M. Schuhmacher, J. Reschke, D. Eick, D. Marinkovic, T. Wirth, A. Rosenwald, et al. 2007. C-myc activation impairs the NF-kappaB and the interferon response: implications for the pathogenesis of Burkitt's lymphoma. Int. J. Cancer 120: 1387-1395. (Pubitemid 46355371)
14. Seliger, B., F. M. Marincola, S. Ferrone, and H. Abken. 2008. The complex role of B7 molecules in tumor immunology. Trends Mol. Med. 14: 550-559.
15. Dong, H., G. Zhu, K. Tamada, and L. Chen. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5: 1365-1369.
16. Wang, S., and L. Chen. 2011. Immunobiology of cancer therapies targeting CD137 and B7-H1/PD-1 cosignal pathways. Curr. Top. Microbiol. Immunol. 344: 245-267.
17. Keir, M. E., M. J. Butte, G. J. Freeman, and A. H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26: 677-704. (Pubitemid 351600389)
18. Dong, H., and X. Chen. 2006. Immunoregulatory role of B7-H1 in chronicity of inflammatory responses. Cell. Mol. Immunol. 3: 179-187.
19. Eppihimer, M. J., J. Gunn, G. J. Freeman, E. A. Greenfield, T. Chernova, J. Erickson, and J. P. Leonard. 2002. Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation 9: 133-145. (Pubitemid 135684689)
20. Lee, S. K., S. H. Seo, B. S. Kim, C. D. Kim, J. H. Lee, J. S. Kang, P. J. Maeng, and J. S. Lim. 2005. IFN-gamma regulates the expression of B7-H1 in dermal fibroblast cells. J. Dermatol. Sci. 40: 95-103.
21. Mühlbauer, M., M. Fleck, C. Schütz, T. Weiss, M. Froh, C. Blank, J. Schölmerich, and C. Hellerbrand. 2006. PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis. J. Hepatol. 45: 520-528. (Pubitemid 44307379)
22. Kondo, A., T. Yamashita, H. Tamura, W. Zhao, T. Tsuji, M. Shimizu, E. Shinya, H. Takahashi, K. Tamada, L. Chen, et al. 2010. Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule, B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes. Blood 116: 1124-1131.
23. Schreiner, B., M. Mitsdoerffer, B. C. Kieseier, L. Chen, H. P. Hartung, M. Weller, and H. Wiendl. 2004. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. J. Neuroimmunol. 155: 172-182. (Pubitemid 39165790)
24. Dong, H., S. E. Strome, D. R. Salomao, H. Tamura, F. Hirano, D. B. Flies, P. C. Roche, J. Lu, G. Zhu, K. Tamada, et al. 2002. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8: 793-800.
25. Kim, Y. S., G. B. Park, H. K. Lee, H. Song, I. H. Choi, W. J. Lee, and D. Y. Hur. 2008. Cross-linking of B7-H1 on EBV-transformed B cells induces apoptosis through reactive oxygen species production, JNK signaling activation, and fasL expression. J. Immunol. 181: 6158-6169.
26. Youlyouz-Marfak, I., N. Gachard, C. Le Clorennec, I. Najjar, F. Baran-Marszak, L. Reminieras, E. May, G. W. Bornkamm, R. Fagard, and J. Feuillard. 2008. Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents. Cell Death Differ. 15: 376-385.
27. Kempkes, B., D. Spitkovsky, P. Jansen-Dürr, J. W. Ellwart, E. Kremmer, H. J. Delecluse, C. Rottenberger, G. W. Bornkamm, and W. Hammerschmidt. 1995. B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO J. 14: 88-96.
28. Pajic, A., D. Spitkovsky, B. Christoph, B. Kempkes, M. Schuhmacher, M. S. Staege, M. Brielmeier, J. Ellwart, F. Kohlhuber, G. W. Bornkamm, et al. 2000. Cell cycle activation by c-myc in a burkitt lymphoma model cell line. Int. J. Cancer 87: 787-793. (Pubitemid 30660555)
29. Gabert, J., E. Beillard, V. H. van der Velden, W. Bi, D. Grimwade, N. Pallisgaard, G. Barbany, G. Cazzaniga, J. M. Cayuela, H. Cavé, et al. 2003. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia 17: 2318-2357. (Pubitemid 38072573)
30. Faumont, N., C. Le Clorennec, P. Teira, G. Goormachtigh, J. Coll, Y. Canitrot, C. Cazaux, J. S. Hoffmann, P. Brousset, G. Delsol, et al. 2009. Regulation of DNA polymerase beta by the LMP1 oncoprotein of EBV through the nuclear factor-kappaB pathway. Cancer Res. 69: 5177-5185.
31. Baran-Marszak, F., J. Feuillard, I. Najjar, C. Le Clorennec, J. M. Béchet, I. Dusanter-Fourt, G. W. Bornkamm, M. Raphaël, and R. Fagard. 2004. Differential roles of STAT1alpha and STAT1beta in fludarabine-induced cell cycle arrest and apoptosis in human B cells. Blood 104: 2475-2483. (Pubitemid 39331850)
32. Gomez-Curet, I., R. S. Perkins, R. Bennett, K. L. Feidler, S. P. Dunn, and L. J. Krueger. 2006. c-Myc inhibition negatively impacts lymphoma growth. J. Pediatr. Surg. 41: 207-211. (Pubitemid 43067518)
33. Cho, H. Y., S. W. Lee, S. K. Seo, I. W. Choi, I. Choi, and S. W. Lee. 2008. Interferon-sensitive response element (ISRE) is mainly responsible for IFN-alpha-induced upregulation of programmed death-1 (PD-1) in macrophages. Biochim. Biophys. Acta 1779: 811-819.
34. Blott, E. J., and G. M. Griffiths. 2002. Secretory lysosomes. Nat. Rev. Mol. Cell Biol. 3: 122-131.
35. Iida, T., H. Ohno, C. Nakaseko, M. Sakuma, M. Takeda-Ezaki, H. Arase, E. Kominami, T. Fujisawa, and T. Saito. 2000. Regulation of cell surface expression of CTLA-4 by secretion of CTLA-4-containing lysosomes upon activation of CD4+ T cells. J. Immunol. 165: 5062-5068.
36. Chen, R., X. Jiang, D. Sun, G. Han, F. Wang, M. Ye, L. Wang, and H. Zou. 2009. Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J. Proteome Res. 8: 651-661.
37. Kundra, R., and S. Kornfeld. 1999. Asparagine-linked oligosaccharides protect Lamp-1 and Lamp-2 from intracellular proteolysis. J. Biol. Chem. 274: 31039-31046.
38. Holt, O. J., F. Gallo, and G. M. Griffiths. 2006. Regulating secretory lysosomes. J. Biochem. 140: 7-12. (Pubitemid 44433540)
39. Pols, M. S., and J. Klumperman. 2009. Trafficking and function of the tetraspanin CD63. Exp. Cell Res. 315: 1584-1592.
40. Eitzen, G. 2003. Actin remodeling to facilitate membrane fusion. Biochim. Biophys. Acta 1641: 175-181. (Pubitemid 36952597)
41. Lanzetti, L. 2007. Actin in membrane trafficking. Curr. Opin. Cell Biol. 19: 453-458. (Pubitemid 47268758)
42. Kuystermans, D., M. J. Dunn, and M. Al-Rubeai. 2010. A proteomic study of cMyc improvement of CHO culture. BMC Biotechnol. 10: 25.
43. Sauzeau, V., I. M. Berenjeno, C. Citterio, and X. R. Bustelo. 2010. A transcriptional cross-talk between RhoA and c-Myc inhibits the RhoA/Rock-dependent cytoskeleton. Oncogene 29: 3781-3792.
44. Shiio, Y., S. Donohoe, E. C. Yi, D. R. Goodlett, R. Aebersold, and R. N. Eisenman. 2002. Quantitative proteomic analysis of Myc oncoprotein function. EMBO J. 21: 5088-5096.
45. Tamura, H., K. Ogata, H. Dong, and L. Chen. 2003. Immunology of B7-H1 and its roles in human diseases. Int. J. Hematol. 78: 321-328. (Pubitemid 37532387)
46. Hotchkiss, R. S., and S. Opal. 2010. Immunotherapy for sepsis - a new approach against an ancient foe. N. Engl. J. Med. 363: 87-89.
47. Huang, X., F. Venet, Y. L. Wang, A. Lepape, Z. Yuan, Y. Chen, R. Swan, H. Kherouf, G. Monneret, C. S. Chung, and A. Ayala. 2009. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc. Natl. Acad. Sci. USA 106: 6303-6308.
48. Kieff, E. D., and A. B. Rickinson. 2007. Epstein Barr virus and its replication. In Fields Virology. D. M. Knipe, and P. M. Howley, eds. Vol. 2. Linppicott Williams & Wilkins, Philadelphia, p. 2603-2654.
49. Lee, S. J., B. C. Jang, S. W. Lee, Y. I. Yang, S. I. Suh, Y. M. Park, S. Oh, J. G. Shin, S. Yao, L. Chen, and I. H. Choi. 2006. Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274). FEBS Lett. 580: 755-762. (Pubitemid 43152293)
50. Kaiser, C., G. Laux, D. Eick, N. Jochner, G. W. Bornkamm, and B. Kempkes. 1999. The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. J. Virol. 73: 4481-4484. (Pubitemid 29189900)
51. Laherty, C. D., H. M. Hu, A. W. Opipari, F. Wang, and V. M. Dixit. 1992. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J. Biol. Chem. 267: 24157-24160.
52. Yamamoto, R., M. Nishikori, M. Tashima, T. Sakai, T. Ichinohe, A. Takaori-Kondo, K. Ohmori, and T. Uchiyama. 2009. B7-H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma. Cancer Sci. 100: 2093-2100.
53. Hiltbold, E. M., and P. A. Roche. 2002. Trafficking of MHC class II molecules in the late secretory pathway. Curr. Opin. Immunol. 14: 30-35. (Pubitemid 34085104)
54. Owada, T., N. Watanabe, M. Oki, Y. Oya, Y. Saito, T. Saito, I. Iwamoto, T. L. Murphy, K. M. Murphy, and H. Nakajima. 2010. Activation-induced accumulation of B and T lymphocyte attenuator at the immunological synapse in CD41 T cells. J. Leukoc. Biol. 87: 425-432.
55. Blott, E. J., G. Bossi, R. Clark, M. Zvelebil, and G. M. Griffiths. 2001. Fas ligand is targeted to secretory lysosomes via a proline-rich domain in its cytoplasmic tail. J. Cell Sci. 114: 2405-2416. (Pubitemid 32684796)
56. Koguchi, Y., T. J. Thauland, M. K. Slifka, and D. C. Parker. 2007. Preformed CD40 ligand exists in secretory lysosomes in effector and memory CD41 T cells and is quickly expressed on the cell surface in an antigen-specific manner. Blood 110: 2520-2527. (Pubitemid 47523174)
57. Cahir-McFarland, E. D., K. Carter, A. Rosenwald, J. M. Giltnane, S. E. Henrickson, L. M. Staudt, and E. Kieff. 2004. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. J. Virol. 78: 4108-4119. (Pubitemid 38437217)
58. Dellis, O., A. Arbabian, J. P. Brouland, T. Kovàcs, M. Rowe, C. Chomienne, I. Joab, and B. Papp. 2009. Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus latent membrane protein-1. Mol. Cancer 8: 59.
59. Dellis, O., A. Arbabian, B. Papp, M. Rowe, I. Joab, and C. Chomienne. 2011. Epstein-Barr virus latent membrane protein 1 increases calcium influx through store-operated channels in B lymphoid cells. J. Biol. Chem. 286: 18583-18592.
60. Dessinioti, C., A. J. Stratigos, D. Rigopoulos, and A. D. Katsambas. 2009. A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes. Exp. Dermatol. 18: 741-749.